|
a |
|
b/README.md |
|
|
1 |
## Comprehensive Clinical, Pathological and Follow-up Dataset of Prostate Cancer Patients |
|
|
2 |
###Creators |
|
|
3 |
Başaranoğlu, Mert |
|
|
4 |
|
|
|
5 |
### Description |
|
|
6 |
This dataset contains comprehensive clinical, pathological, and follow-up data from 600 prostate cancer patients. The data includes: |
|
|
7 |
|
|
|
8 |
### Clinical Parameters: |
|
|
9 |
- Patient demographics (age) |
|
|
10 |
- Initial diagnosis details (PSA, clinical stage, biopsy Gleason score) |
|
|
11 |
- Risk stratification |
|
|
12 |
- Laboratory values (albumin, lymphocyte count, CRP, NLR, CALLY Index) |
|
|
13 |
- Comorbidity scores |
|
|
14 |
|
|
|
15 |
### Treatment Information: |
|
|
16 |
- Treatment type (surgery, radiotherapy, hormone therapy, or combinations) |
|
|
17 |
- Treatment dates |
|
|
18 |
- Radiation doses |
|
|
19 |
- Androgen deprivation therapy details |
|
|
20 |
|
|
|
21 |
### Pathological Outcomes: |
|
|
22 |
- Pathological stage |
|
|
23 |
- Surgical margin status |
|
|
24 |
- Final Gleason score |
|
|
25 |
|
|
|
26 |
### Follow-up Data: |
|
|
27 |
- PSA measurements (nadir and at 3, 6, 12 months) |
|
|
28 |
- Biochemical recurrence status and dates |
|
|
29 |
- Metastasis information |
|
|
30 |
- Survival status |
|
|
31 |
- Last follow-up dates |
|
|
32 |
|
|
|
33 |
The dataset is anonymized and includes 30 variables across 600 patients, making it valuable for: |
|
|
34 |
- Clinical research in prostate cancer |
|
|
35 |
- Outcome prediction studies |
|
|
36 |
- Treatment response analysis |
|
|
37 |
- Risk stratification model development |
|
|
38 |
- Machine learning applications in oncology |
|
|
39 |
|
|
|
40 |
Data format: CSV file |
|
|
41 |
Time period: 2020-2024 |